In line with this observation, Analog-1, a pharmacological activator of RNF5, exerted a potent cytotoxic effect on in vitro and in vivo neuroblastoma and melanoma models by modulating the metabolism, reducing the growth and inducing the death of tumor cells. This evidence concerns the gene RNF5 and melanoma.